Unraveling the Mechanisms of Sensitivity to Anti-FGF Therapies in Imatinib-Resistant Gastrointestinal Stromal Tumors (GIST) Lacking Secondary KIT Mutations
揭示缺乏继发性 KIT 突变的伊马替尼耐药胃肠道间质瘤 (GIST) 对抗 FGF 疗法的敏感性机制
期刊:Cancers
影响因子:
doi:10.3390/cancers15225354
Sergei Boichuk, Pavel Dunaev, Vera Skripova, Aigul Galembikova, Firyuza Bikinieva, Elena Shagimardanova, Guzel Gazizova, Ruslan Deviatiiarov, Elena Valeeva, Ekaterina Mikheeva, Maria Vasilyeva, Pavel Kopnin, Vladimir Strelnikov, Ramziya Kiyamova
肿瘤
胃癌
FCM
IF
IHC-P
WB
Human
FGF2